[1] Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev, 2015, 87:3-14.
[2] Zhao Q, Xie D, Liu H, et al. SSCMDA: spy and super cluster strategy for MiRNA-disease association prediction. Oncotarget, 2018, 9:1826-1842.
[3] Ciccacci C, Politi C, Biancone L, et al. Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases. Mol Diagn Ther, 2017, 21:1-8.
[4] Satishchandran A, Ambade A, Rao S, et al. MicroRNA 122, regulated by grlh2, protects livers of mice and patients from ethanol-induced liver disease. Gastroenterology,2018, 154:238-252.
[5] Yueh C, Yuh-Lih C, Hsin-Yang L, et al. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model. Acta Biomater, 2015, 13:228-244.
[6] Luna JM, Michailidis E, Rice CM. Mopping up miRNA: an integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. J Hepatol, 2016, 64:257-259.
[7] Wang WJ, Lai RT, Lu J, et al. Correlation between circulating miR‐122 and prognosis of chronic HBV‐related liver failure.J Dig Dis, 2016, 17:334-339.
[8] Kitab B, Alj HS, Ezzikouri S, et al. MicroRNAs as important players in host-hepatitis b virus interactions.J Clin Transl Hepatol, 2015;3:149-161.
[9] 江小梅, 彭杰文. microRNA-122在HBV相关性肝癌中的表达及意义. 广东医学, 2017, 38:916-917.
[10] Hayes C, Kazuaki C. MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int J Mol Sci, 2016, 17:280-297.
[11] Vliegenthart AD, Berends C, Potter CM, et al. microRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol, 2017, 83:2027-2033.
[12] 宋磊, 张中瑞, 贺蕾, 等. 微小RNA-122在异烟肼所致小鼠抗结核药物性肝损伤中的动态变化. 中国药理学与毒理学杂志, 2014, 28: 569-574.
[13] 张清清, 陆伦根. miRNA诊断慢性肝病及肝纤维化价值的研究进展. 诊断学理论与实践, 2015:367-370.
[14] Ghoshal K, Thakral S. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as mirna mimic and antimir. Curr Gene Ther, 2015, 15: 142-150.
[15] Quoc NB, Ndn P, Ngan TK, et al. Expression of plasma hsa-miR122 in HBV-related hepatocellular carcinoma (HCC) in vietnamese patients. Microrna, 2018,7:92-99.
[16] 李玉红, 朱凌妍, 田慎谦, 等. miR-122在异烟肼肝损伤大鼠中的调控机制. 中国医院药学杂志, 2016, 36:97-102.
[17] Aalaei-Andabili SH, Rezaei N. MicroRNAs (MiRs) precisely regulate immune system development and function in immunosenescence process.Int Rev Immunol, 2015, 35:1-10.
[18] Amr KS, Elmawgoud Atia HA, Elazeem Elbnhawy RA, et al. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. Genes Dis, 2017, 4:215-221. |
